Rimeporide as a first- in-class NHE-1 inhibitor: Results of a phase Ib trial in young patients with Duchenne Muscular Dystrophy

por Previtali, Stefano C., Gidaro, Teresa, Díaz-Manera, Jordi, Zambon, Alberto, Carnesecchi, Stephanie, Roux-Lombard, Pascale, Spitali, Pietro, Signorelli, Mirko, Szigyarto, Cristina Al-Khalili, Johansson, Camilla, Gray, Julian, Labolle, Delphine, Porte Thomé, Florence, Pitchforth, Jacqueline, Domingos, Joana, Muntoni, Francesco
Publicado 2020